Evaluation of Anti-Toxoplasma gondii Effect of Ursolic Acid as a Novel Toxoplasmosis Inhibitor.

about

Evaluation of Anti-Toxoplasma gondii Effect of Ursolic Acid as a Novel Toxoplasmosis Inhibitor.

Item

http://www.wikidata.org/entity/Q54215294

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Evaluation of Anti-Toxoplasma ...... Novel Toxoplasmosis Inhibitor.

@en

Evaluation of Anti-Toxoplasma ...... Novel Toxoplasmosis Inhibitor.

@nl

type

Item

label

Evaluation of Anti-Toxoplasma ...... Novel Toxoplasmosis Inhibitor.

@en

Evaluation of Anti-Toxoplasma ...... Novel Toxoplasmosis Inhibitor.

@nl

prefLabel

Evaluation of Anti-Toxoplasma ...... Novel Toxoplasmosis Inhibitor.

@en

Evaluation of Anti-Toxoplasma ...... Novel Toxoplasmosis Inhibitor.

@nl

P1476

Evaluation of Anti-Toxoplasma ...... Novel Toxoplasmosis Inhibitor.

@en

P2093

In Ah Lee

http://www.w3.org/2001/XMLSchema#string

Won Hyung Choi

http://www.w3.org/2001/XMLSchema#string

P2860

Host cell manipulation by the human pathogen Toxoplasma gondii

Anti-infective immunoadhesins from plants.

The Effect of Ursolic Acid on Leishmania (Leishmania) amazonensis Is Related to Programed Cell Death and Presents Therapeutic Potential in Experimental Cutaneous Leishmaniasis

Signaling during the invasion of host cells by Toxoplasma gondii.

Potent anti-inflammatory activity of ursolic acid, a triterpenoid antioxidant, is mediated through suppression of NF-κB, AP-1 and NF-AT

In vitro anti-Toxoplasma gondii activity of root extract/fractions of Eurycoma longifolia Jack.

Spectral studies on 33258 Hoechst and related bisbenzimidazole dyes useful for fluorescent detection of deoxyribonucleic acid synthesis.

Secretory traffic in the eukaryotic parasite Toxoplasma gondii: less is more

In vitro evaluation of β-carboline alkaloids as potential anti-Toxoplasma agents.

Ursolic and oleanolic acids as antimicrobial and immunomodulatory compounds for tuberculosis treatment

P31

scholarly article

P356

10.3390/PH11020043

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29747388

http://www.w3.org/2001/XMLSchema#string

P921

Toxoplasma gondii

toxoplasmosis

P932

6026977

http://www.w3.org/2001/XMLSchema#string